{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:56:49Z","timestamp":1790740609608,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01224","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T11:21:15Z","timestamp":1559128875000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180"],"prefix":"10.3389","volume":"10","author":[{"given":"Yosuke","family":"Mai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Nishie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"26","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1468-3083.2011.04062.x","article-title":"Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin","volume":"26","author":"Skandalis","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/bjd.14601","article-title":"Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database","volume":"175","author":"B\u00e9n\u00e9","year":"2016","journal-title":"Br J Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jid.2018.01.027","article-title":"Vildagliptin significantly increases the risk of bullous pemphigoid: a finnish nationwide registry study","volume":"138","author":"Varpuluoma","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jaad.2017.12.038","article-title":"Dipeptidyl pepidase IV inhibitors, a risk factor for bullous pemphigoid: retrospective multicenter case-control study from France and Switzerland","volume":"78","author":"Benzaquen","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jamadermatol.2018.2352","article-title":"Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: estimating the risk of the new agents and characterizing the patients","volume":"154","author":"Kridin","year":"2018","journal-title":"JAMA Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.2337\/dc18-0210","article-title":"Bullous pemphigoid and dipeptidyl peptidase 4 inhibitors: a disproportionality analysis based on the japanese adverse drug event report database","volume":"41","author":"Arai","year":"2018","journal-title":"Diabetes Care"},{"key":"B9","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jid.2018.10.045","article-title":"Higher frequency of dipeptidyl peptidase IV inhibitor intake in bullous pemphigoid patients than in the French general population","volume":"139","author":"Plaquevent","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jid.2017.11.023","article-title":"HLA-DQB1*03:01 as a biomarker for genetic susceptibility to bullous pemphigoid induced by DPP-4 inhibitors","volume":"138","author":"Ujiie","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/bjd.16479","article-title":"Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors","volume":"178","author":"Horikawa","year":"2018","journal-title":"Br J Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/bjd.16656","article-title":"Detection of anti-BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid: a report of three patients","volume":"179","author":"Mai","year":"2018","journal-title":"Br J Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2340\/00015555-3010","article-title":"Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: recurrence with epitope spreading","volume":"98","author":"Takama","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological- image analysis","volume":"28","author":"Schindelin","year":"2012","journal-title":"Nat Method"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-007-0734-0","article-title":"The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin disease","volume":"299","author":"Sitaru","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1172\/JCI114508","article-title":"Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis","volume":"85","author":"Zone","year":"1990","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/1523-1747.ep12345782","article-title":"LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells","volume":"106","author":"Marinkovich","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1093\/emboj\/cdf532","article-title":"Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs","volume":"21","author":"Franzke","year":"2002","journal-title":"EMBO J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/jid.2008.424","article-title":"Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97","volume":"129","author":"Hofmann","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1046\/j.1523-1747.2000.0202a-7.x","article-title":"IgA antibodies of linear IgA bullous dermatosis recognize the 15th collagenous domain of BP180","volume":"115","author":"Nie","year":"","journal-title":"J Invest Dermatol. ("},{"key":"B23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jdermsci.2014.07.008","article-title":"Major cleavage-dependent epitopes for linear IgA bullous dermatosis are formed at the boundary between the non-collagenous 16A and collagenous 15 domains of BP180","volume":"76","author":"Yamauchi","year":"2014","journal-title":"J Dermatol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.jid.2017.07.831","article-title":"C-termial processing of collagen XVII induces neoepitopes for linear IgA dermatosis","volume":"137","author":"Toyonaga","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.jid.2017.09.001","article-title":"Production of neoepitopes by dnamic structural changes on BP180\/type XVII collagen","volume":"137","author":"Hashimoto","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jdermsci.2017.07.012","article-title":"IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid","volume":"88","author":"Dainichi","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jaut.2016.06.019","article-title":"IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid","volume":"73","author":"Zuo","year":"2016","journal-title":"J Autoimmun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1582-4934.2007.00081.x","article-title":"IgG4 autoantibodies induce dermal-epidermal separation","volume":"11","author":"Mihai","year":"2007","journal-title":"J Cell Mol Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjd.14411","article-title":"Bullous pemphigoid suggestive of complement-independent blister formation with anti-BP180 IgG4 autoantibodies","volume":"175","author":"Dainichi","year":"2016","journal-title":"Br J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.4049\/jimmunol.177.5.3398","article-title":"Role of FcRs in animal model of autoimmune bullous pemphigoid","volume":"177","author":"Zhao","year":"2006","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01224\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T11:21:17Z","timestamp":1559128877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01224\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2019.01224"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01224","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"article-number":"1224"}}